Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concomitant Radiochemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01203735
What this trial is testing

Valproic Acid With Chemoradiotherapy for Non-Small-Cell Lung Cancer

Who this might be right for
Locally Advanced Inoperable Non-small-lung Cancer
Soroka University Medical Center 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06916117
What this trial is testing

Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC

Who this might be right for
Locally Advanced Cervical Cancer
RenJi Hospital 30
Not applicableLooking for participantsNCT07711626
What this trial is testing

Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT

Who this might be right for
Head and Neck NeoplasmsXerostomiaCancer-related Fatigue+1 more
Tzu Chi University 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05904015
What this trial is testing

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Who this might be right for
Lung Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 80
Early research (Phase 1)Study completedNCT02964455
What this trial is testing

Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 12
Early research (Phase 1)UnknownNCT04882033
What this trial is testing

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Limited Stage
Tianjin Medical University Cancer Institute and Hospital 9
Not applicableUnknownNCT01336452
What this trial is testing

Noninvasive Surrogate Marker for Advanced Hepatocellular Carcinoma Response to Concurrent Chemoradiotherapy: MR Perfusion, Contrast Enhanced Ultrasound and Biomarkers

Who this might be right for
Advanced Adult Hepatocellular Carcinoma
Yonsei University 30
Testing effectiveness (Phase 2)Ended earlyNCT01720563
What this trial is testing

A Phase II Trial of PG2 in Patients With Advanced Pharyngeal or Laryngeal Squamous Cell Carcinoma Under Concurrent Chemoradiotherapy

Who this might be right for
Cancer-related Fatigue
PhytoHealth Corporation 17
Testing effectiveness (Phase 2)UnknownNCT00506623
What this trial is testing

Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer

Who this might be right for
Rectal NeoplasmNeoadjuvant Therapy
National Cancer Center, Korea 48
Testing effectiveness (Phase 2)UnknownNCT02753140
What this trial is testing

Concurrent Chemoradiotherapy(CRT) in Locally Advanced(LA) SCCHN vs Cetuximab With Radiotherapy (RT) After Neoadjuvant Chemotherapy

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 60
Post-approval studies (Phase 4)Ended earlyNCT02721550
What this trial is testing

A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC

Who this might be right for
Esophageal Neoplasms
Shandong Cancer Hospital and Institute 2
Large-scale testing (Phase 3)Active Not RecruitingNCT07306663
What this trial is testing

Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical Study

Who this might be right for
Esophageal Cancer
Jiangsu Cancer Institute & Hospital 242
Not applicableUnknownNCT04161352
What this trial is testing

Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC

Who this might be right for
Unresectable Stage III NSCLC
Zhejiang Cancer Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00228488
What this trial is testing

Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma

Who this might be right for
Head and Neck Cancer
AstraZeneca 60
Testing effectiveness (Phase 2)UnknownNCT04015661
What this trial is testing

Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Patients With LA-NPC

Who this might be right for
Nasopharyngeal Carcinoma
Fuzhou General Hospital 92
Testing effectiveness (Phase 2)UnknownNCT05351320
What this trial is testing

WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Jinming Yu 40
Testing effectiveness (Phase 2)Study completedNCT00169247
What this trial is testing

Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation

Who this might be right for
Larynx CancerHypopharynx Cancer
Groupe Oncologie Radiotherapie Tete et Cou 156
Not applicableStudy completedNCT01836926
What this trial is testing

TaTME Versus Open Intersphincteric Resection After Neoadjuvant Concurrent Chemoradiotherapy.

Who this might be right for
Rectal Cancer
Osama Mohammad Ali ElDamshety 110
Large-scale testing (Phase 3)Looking for participantsNCT07177443
What this trial is testing

Serplulimab Combined With Induction Chemotherapy and Radiotherapy in Nasopharyngeal Carcinoma

Who this might be right for
Locally Advanced Nasopharyngeal Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 710
Testing effectiveness (Phase 2)Active Not RecruitingNCT06771596
What this trial is testing

Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix

Who this might be right for
Uterine Cervical Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 43
Next Page